Port Site Metastasis After Robotic Assisted Laparoscopic Radical Prostatectomy: Diagnosis via Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT

Authors

Joon Yau Leong, Thomas Jefferson UniversityFollow
Maria D'Amico, Thomas Jefferson UniversityFollow
Courtney Capella, Thomas Jefferson UniversityFollow
Leonard Gomella, Thomas Jefferson UniversityFollow
Joseph Izes, Thomas Jefferson UniversityFollow

Document Type

Report

Publication Date

5-28-2025

Comments

This article is the author's final published version in Urology Case Reports, Volume 61, 2025, Article number 103082.

The published version is available at https://doi.org/10.1016/j.eucr.2025.103082.

Copyright © 2025 The Authors

Abstract

We present a case of port site metastasis (PSM) that was identified in an 82-year-old man with an elevated prostate-specific antigen (PSA) to 3.9 ng/mL, concerning for biochemical recurrence after robotic-assisted radical prostatectomy, adjuvant radiation, and six months of androgen deprivation therapy with an undetectable PSA post-treatment over 10 years ago. A 2.1 cm solitary tracer avid nodule on the right lateral abdominal wall with no other evidence of recurrence or metastatic disease was found on prostate-specific membrane antigen (PSMA)–targeted ¹⁸F-DCFPyL PET/CT scan. The patient underwent local excision of this metastatic lesion, and final pathology revealed metastatic prostatic adenocarcinoma.

Recommended Citation

Leong, Joon Yau; D'Amico, Maria; Capella, Courtney; Gomella, Leonard; and Izes, Joseph, "Port Site Metastasis After Robotic Assisted Laparoscopic Radical Prostatectomy: Diagnosis via Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT" (2025). Department of Urology Faculty Papers. Paper 93.
https://jdc.jefferson.edu/urologyfp/93

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID

40510628

Language

English